What does the licensing of teplizumab mean for diabetes care?

被引：1
作者：
Quinn, Lauren M. [1 ]
Swaby, Rabbi [2 ]
Tatovic, Danijela [2 ]
Narendran, Parth [3 ]
Besser, Rachel E. J. [2 ,4 ]
Dayan, Colin M. [2 ,5 ]
机构：
[1] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, England
[2] Univ Oxford, Wellcome Ctr Human Genet, Oxford, England
[3] Univ Hosp Birmingham, Dept Diabet, Birmingham, England
[4] John Radcliffe Hosp, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Dept Paediat, Oxford, England
[5] Cardiff Univ, Sch Med, Diabet Res Grp, Cardiff, Wales
来源：
DIABETES OBESITY & METABOLISM | 2023年 / 25卷 / 08期
关键词：
autoantibodies; screening; teplizumab; type; 1; diabetes; PRESERVES C-PEPTIDE; ISLET AUTOANTIBODIES; EXCESS MORTALITY; YOUNG-ADULTS; TYPE-1; ONSET; PROGRESSION; CHILDREN; RISK; KETOACIDOSIS;
D O I：
10.1111/dom.15071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2051 / 2057
页数：7
相关论文
共 58 条
  • [1] Immunotherapy for type 1 diabetes
    Allen, L. A.
    Dayan, C. M.
    [J]. BRITISH MEDICAL BULLETIN, 2021, 140 (01) : 76 - 90
  • [2] Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes
    Anderson, Randy L.
    DiMeglio, Linda A.
    Mander, Adrian P.
    Dayan, Colin M.
    Linsley, Peter S.
    Herold, Kevan C.
    Marinac, Marjana
    Ahmed, Simi T.
    [J]. DIABETES CARE, 2022, 45 (10) : 2189 - 2201
  • [3] International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study
    Anderzen, Johan
    Hermann, Julia M.
    Samuelsson, Ulf
    Charalampopoulos, Dimitrios
    Svensson, Jannet
    Skrivarhaug, Torild
    Froehlich-Reiterer, Elke
    Maahs, David M.
    Akesson, Karin
    Kapellen, Thomas
    Fritsch, Maria
    Birkebaek, Niels H.
    Drivvoll, Ann K.
    Miller, Kellee
    Stephenson, Terence
    Hofer, Sabine E.
    Fredheim, Siri
    Kummernes, Siv J.
    Foster, Nicole
    Amin, Rakesh
    Hilgard, Doerte
    Rami-Merhar, Birgit
    Dahl-Jorgensen, Knut
    Clements, Mark
    Hanas, Ragnar
    Holl, Reinhard W.
    Warner, Justin T.
    [J]. PEDIATRIC DIABETES, 2020, 21 (04) : 621 - 627
  • [4] Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
    Aronson, Ronnie
    Gottlieb, Peter A.
    Christiansen, Jens S.
    Donner, Thomas W.
    Bosi, Emanuele
    Bode, Bruce W.
    Pozzilli, Paolo
    [J]. DIABETES CARE, 2014, 37 (10) : 2746 - 2754
  • [5] Bergenstal RM, 2021, LANCET, V397, P208, DOI 10.1016/S0140-6736(20)32514-9
  • [6] Screening children for type 1 diabetes Worth serious consideration, including further research
    Besser, R. E. J.
    Ng, S. M.
    Robertson, E. J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 375
  • [7] ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and adolescents
    Besser, Rachel E. J.
    Bell, Kirstine J.
    Couper, Jenny J.
    Ziegler, Anette-G
    Wherrett, Diane K.
    Knip, Mikael
    Speake, Cate
    Casteels, Kristina
    Driscoll, Kimberly A.
    Jacobsen, Laura
    Craig, Maria E.
    Haller, Michael J.
    [J]. PEDIATRIC DIABETES, 2022, 23 (08) : 1175 - 1187
  • [8] General population screening for childhood type 1 diabetes: is it time for a UK strategy?
    Besser, Rachel Elizabeth Jane
    Ng, Sze May
    Gregory, John W.
    Dayan, Colin M.
    Randell, Tabitha
    Barrett, Timothy
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (09) : 790 - 795
  • [9] Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes
    Boughton, Charlotte K.
    Allen, Janet M.
    Ware, Julia
    Wilinska, Malgorzata E.
    Hartnell, Sara
    Thankamony, Ajay
    Randell, Tabitha
    Ghatak, Atrayee
    Besser, Rachel E. J.
    Elleri, Daniela
    Trevelyan, Nicola
    Campbell, Fiona M.
    Sibayan, Judy
    Calhoun, Peter
    Bailey, Ryan
    Dunseath, Gareth
    Hovorka, Roman
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (10) : 882 - 893
  • [10] Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study
    Charleer, Sara
    De Block, Christophe
    Van Huffel, Liesbeth
    Broos, Ben
    Fieuws, Steffen
    Nobels, Frank
    Mathieu, Chantal
    Gillard, Pieter
    [J]. DIABETES CARE, 2020, 43 (02) : 389 - 397
123456